ENP109: Anti-Obesity Medications (CME credit available)

In recent years, we have seen tremendous growth not just in the popularity of anti-obesity medications, but also in the medications themselves, how effective they are, how many there are. What exactly has changed during this rapid evolution? How safe and effective are these medications today? What challenges still exist in using them? To help answer these questions, host Aaron Lohr speaks with , professor of medicine, medical director of Vanderbilt Obesity Medicine, and founding program director of the Obesity Medicine Fellowship at Vanderbilt University Medical Center. Dr. Srivastava presented at the Endocrine Society’s Obesity Fellows Conference in September 2025. The title of her presentation was “Pharmacological Approaches to Treating and Understanding Complicated Obesity.” Listening to this episode can earn you 0.5 ABIM MOC points and 0.5 AMA PRA Category 1 credits. If you are interested in those points and credits, . You can find a link in this episode’s show notes. After that pre-test, listen to this episode , then take the post-test. This episode is made possible by educational grants from Lilly and Novo Nordisk. Show notes are available at — for helpful links or to hear more podcast episodes, visit

You can listen to ENP109: Anti-Obesity Medications (CME credit available) online on Radio and Podcast. Open the player on this page to stream the available audio.

ENP109: Anti-Obesity Medications (CME credit available) is an episode from Endocrine News Podcast by Endocrine Society.

This episode is 13:15 long.

This episode was published on Jan 7, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Endocrine News Podcast when more episodes are available from the podcast feed.